<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31165612</article-id><article-id pub-id-type="pmc">6852450</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0291</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Is Hypoalbuminemia a Predictor for Acute Kidney Injury after Coronary
Bypass Grafting in Diabetes Mellitus Patients?</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4353-1322</contrib-id><name><surname>Aksoy</surname><given-names>Rezan</given-names></name><role>MD</role><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Adademir</surname><given-names>Taylan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Yilmaz</surname><given-names>Ekrem</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Cevirme</surname><given-names>Deniz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Sengor</surname><given-names>Mehmet</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Koksal</surname><given-names>Cengiz</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Rabus</surname><given-names>Murat Bulent</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Department of Cardiovascular Surgery, University of Health Sciences,
Kartal Kosuyolu Heart Education and Research Hospital, Istanbul, Turkey.</aff><aff id="aff2">
<label>2</label>Department of Cardiovascular Surgery, Bezmialem Vak&#x00131;f
University, Medical Faculty, Istanbul, Turkey.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Rezan Aksoy</bold>, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-4353-1322">https://orcid.org/0000-0003-4353-1322</ext-link>, Department of
Cardiovascular Surgery, University of Health Sciences, Kartal Kosuyolu Heart
Education and Research Hospital, Cevizli Mahallesi 2, Denizer Caddesi, Cevizli
Kav&#x0015f;a&#x0011f;&#x00131;, Istanbul, Turkey, Zip code: 34865. E-mail:
<email>rezanaksoy@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>565</fpage><lpage>571</lpage><history><date date-type="received"><day>01</day><month>5</month><year>2018</year></date><date date-type="accepted"><day>04</day><month>1</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Acute kidney injury (AKI) is one of the most important complications after
coronary artery bypass grafting (CABG) procedure. Serum albumin, which is an
acute phase reactant, is suggested to be associated with AKI development
subsequent to various surgical procedures. In this study, we research the
relation between preoperative serum albumin levels and postoperative AKI
development in diabetes mellitus (DM) patients undergoing isolated CABG.</p></sec><sec><title>Methods</title><p>We included a total of 634 diabetic patients undergoing CABG (60.5&#x000b1;9.1
years, 65.1% male) into this study, which was performed between September
2009 and January 2014 in a single center. The relation between preoperative
serum albumin levels and postoperative AKI development was observed. AKI was
evaluated and diagnosed using the Kidney Disease: Improving Global Outcomes
(KDIGO) classification.</p></sec><sec><title>Results</title><p>AKI was diagnosed in 230 (36.3%) patients. Multiple logistic regression
analysis was performed to determine the independent predictors of AKI
development. Proteinuria (odds ratio [OR] and 95% confidence interval [CI],
1.066 [1.002-1.135]; <italic>P</italic>=0.043) and low preoperative serum
albumin levels (OR and 95% CI, 0.453 [0.216-0.947];
<italic>P</italic>=0.035) were found to be independent predictors of AKI.
According to the receiver operating characteristic curve analysis, albumin
level &#x0003c;3mg/dL (area under the curve: 0.621 [0.572-0.669],
<italic>P</italic>&#x0003c;0.001) had 83% sensitivity and 10% specificity on
predicting the development of AKI.</p></sec><sec><title>Conclusion</title><p>We observed that a preoperative low serum albumin level was associated with
postoperative AKI development in patients with DM who underwent isolated
CABG procedure. We emphasize that this adjustable albumin level should be
considered before the operation since it is an easy and clinically
implementable management for the prevention of AKI development.</p></sec></abstract><kwd-group><kwd>Coronary Bypass</kwd><kwd>Diabetes Mellitus</kwd><kwd>Hypoalbuminemia</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="42%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="42%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ACC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Aortic
cross-clamping</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">Hgb</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Hemoglobin</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AKI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute kidney injury</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Hypertension</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ANOVA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Analysis of
variance</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AUC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Area under the
curve</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IQR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Interquartile range</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Body mass index</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">KDIGO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Kidney Disease:
Improving Global Outcomes</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LVEF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left ventricular
ejection fraction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Myocardial
infarction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Odds ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CRP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= C-reactive protein</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RDW</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Red cell distribution
width</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DM</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Diabetic mellitus</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ROC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Receiver operating
characteristic</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EDTA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">=
Ethylenediaminetetraacetic acid</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Ejection fraction</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SCr</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Serum creatinine</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">GFR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Glomerular filtration
rate</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SPSS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Statistical Package for
Social Sciences</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Twenty to 30% of all patients undergoing coronary artery bypass grafting (CABG) are
diabetic<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Patients with
type 2 diabetes mellitus (DM) have been reported to show high morbidity and
mortality rates following CABG operations<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Type 2 DM is reported to increase postoperative acute
kidney injury (AKI) development rates in patients undergoing CABG surgery<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>. AKI, which is not rarely seen after cardiac surgery, is
associated with increased morbidity and mortality rates. AKI subsequent to cardiac
surgery is diagnosed in 5-30% of the patients and renal replacement therapy is
required in 1-2% of them<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. And
AKI subsequent to CABG is also associated with longer intensive care unit (ICU) and
in-hospital stays and increased rates of hemodialysis requirement and chronic renal
failure<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. Serum albumin,
which is a plasma protein that has an important role on the regulation of plasma
oncotic pressure, is also is an acute-phase reactant. The normal range of albumin in
serum is 3-5 g/dL<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. In many
studies, hypoalbuminemia subsequent to cardiac surgical procedures was found to be
associated with increased rates of mortality and morbidity<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>]</sup>. There are also studies showing that hypoalbuminemia is
associated with AKI development after various surgical procedures<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. In this study, we aimed to
research the relation between preoperative serum albumin levels and postoperative
AKI development in selected patients with DM undergoing isolated CABG surgery.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This study was performed retrospectively on the perioperative data of 634 diabetic
patients undergoing isolated CABG surgery in a single-center between September 2009
and January 2014. Of the patients, 65.1% (n=413) were male and 34.9% (n=221) were
female. The average age was 60.5&#x000b1;9.1 years. After the local ethical committee
approval, the data of the patients were collected from the archive records, hospital
data recording program, patients' discharge summaries, operative reports, laboratory
results, and radiological images. In this study, the relation between preoperative
serum albumin levels and postoperative AKI development was observed. The AKI
developing and non-AKI groups were compared.</p><p>AKI was diagnosed and evaluated according to the Kidney Disease: Improving Global
Outcomes (KDIGO) classification<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.
The stages of AKI based on KDIGO classification are:</p><p>
<disp-quote><p>Stage 1: Increase in serum creatinine (SCr) &#x02265; 0.3 mg/dL (in 48 hours)
or 1.5 to 1.9 mg/dL multiplied by baseline SCr (in seven days);</p><p>Stage 2: Between 2.0 to 2.9 mg/dL multiplied by baseline SCr;</p><p>Stage 3: 3.0 mg/dL or more multiplied by baseline SCr; increase in SCr
&#x02265; 4.0 mg/dL; or beginning of renal replacement therapy regardless of
a previous KDIGO stage.</p></disp-quote>
</p><p>Preoperative serum albumin levels were measured by the bromocresol green dye-binding
method. The groups were not identified due to reference ranges but AKI development
of patients regarding to serum albumin levels was observed.</p><p>Patients with chronic renal failure requiring hemodialysis or with SCr &#x0003e;1,6 mg/dL
were excluded from this study<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.
And patients excluded from this study had systemic disorders associated with
hypoalbuminemia, which were liver dysfunction, malnourishment, congestive heart
failure, active malignancy, endocrinologic disorders (hypothyroidism,
hyperthyroidism, etc.), lymphoproliferative disease, low hemoglobin (Hgb) levels
(&#x02264;10 g/dL), active infection, and active or chronic autoimmune disease;
patients taking steroids or chemotherapeutic drugs were also excluded.</p><p>Demographic characteristics and preoperative clinical conditions, like age, sex, body
surface area, hypertension (HT) incidence, DM incidence previous myocardial
infarction (MI), and preoperative ejection fraction (EF), were noted. Preoperative
and postoperative laboratory results of creatinine, C-reactive protein (CRP), and
Hgb were also noted. Perioperative data of cardiopulmonary bypass (CPB) and aortic
cross-clamping (ACC) duration, postoperative drainage level, intubation duration,
and ICU and in-hospital stays duration were measured for every individual patient.
Proteinuria was measured by calorimetry.</p><p>In this study, HT was defined as a history of antihypertensive drug intake or blood
pressure measurement &#x02265;140/90 mmHg. In addition, DM was defined as history of
antidiabetic drug intake or a measured fasting blood glucose level &#x0003e;126
mg/dL<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Peripheric
venous blood of 5 to 7 cc was drawn to ethylenediaminetetraacetic acid (EDTA)
vacutainers to prevent clotting from all the patients prior to surgery. All the
hemogram parameters were measured in automatic Abbott CELL-DYN 3700 (Abbott
Laboratory, Abbott Park, Illinois, USA) analyzers.</p><sec><title>Blood Glucose Level Measurements</title><p>Throughout the operation, blood glucose levels of the patients were evaluated
conservatively, once before the CPB and then at hourly intervals with blood gas
measurements. Crystallized insulin (Humulin R(r), Lilly, Indianapolis, USA) was
applied intravenously to control high blood glucose levels. In the ICU, all
patients' blood glucose levels were regulated with an insulin infusion according
to the Portland protocol<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.
The total of the measured values was divided by the number of measurements to
determine the mean blood glucose value during the operation for each patient.
All surgical procedures were performed according to on-pump modern principles
during CABG surgery. During the operation, following the routine application of
anaesthesia, a median sternotomy was applied. A non-pulsatile roller pump and
membrane oxygenator was used for CPB in all patients. The surgical procedure was
performed at moderate systemic hypothermia (28&#x000b0;C-30&#x000b0;C). CPB was applied in a
manner so that the flow rate was 2.2-2.5 L/min/m<sup>2</sup>, mean perfusion
pressure was 50-80 mmHg, and hematocrit values were 20%-25%.</p></sec><sec><title>Statistics</title><p>Statistical analysis was performed using the Statistical Package for Social
Sciences (SPSS) software (SPSS version 21.0, IBM, Armonk, New York). Continuous
variables with normal distribution were presented as mean (standard deviation
[SD]), non-normal variables were reported as median (interquartile range [IQR]),
and categorical variables were reported as percentage. Univariate comparisons
between groups were performed using the chi-square test for categorical
variables and the Student's t-test or Mann-Whitney rank sum test for continuous
variables, as appropriate. Variables with a P-value &#x0003c;0.05 in univariate
analysis were assessed in the multiple logistic regression model to determine
the independent predictors of postoperative AKI. Receiver operating
characteristic (ROC) curves were plotted to determine the optimal cut-off values
for individual parameters in order to predict AKI and to establish the optimal
cut-off points for use in clinical decision making. One-way repeated measure
analysis of variance (ANOVA) was used to determine the change for creatinine
over the first three postoperative days. A <italic>P</italic>-value &#x0003c;0.05 was
considered to be significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>We included a total of 634 diabetic patients (60.59.1 years, 65.1% male) into this
study. Eighty-three of them required coronary endarterectomy procedures with CABG
and 13 underwent cardiac reoperation. The median ACC time was 51 (33-74) minutes.
Mean baseline creatinine level was 1.05&#x000b1;0.60 (ranged from 0.4 to 6.6) mg/dL
and creatinine level at the 48<sup>th</sup> hour was 1.17&#x000b1;0.76 (ranged from
0.3 to 6.6) mg/dL. Two hundred and thirty (36.3%) patients developed AKI according
to KDIGO classification. The preoperative mean blood urea level of the non-AKI group
was 21.4&#x000b1;9.9 mg/dL and of the AKI group was 25.1&#x000b1;12.6 mg/dL
(<italic>P</italic>&#x0003c;0,05). The postoperative mean blood urea level of the
non-AKI group was 20.9&#x000b1;7.9 mg/dL and of the AKI group was 30.2&#x000b1;13.7
mg/dL (<italic>P</italic>&#x0003c;0.05). Preoperative, intraoperative, and postoperative
clinical characteristics of AKI and non-AKI patients were summarized in <xref rid="t1" ref-type="table">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Baseline characteristics of the study subjects.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">AKI (n=230)</th><th align="center" rowspan="1" colspan="1">Non-AKI (n=404)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="15" colspan="1">Preoperative data</td><td align="left" rowspan="1" colspan="1">Male % (N)</td><td align="center" rowspan="1" colspan="1">58.6 (135)</td><td align="center" rowspan="1" colspan="1">68.8 (278)</td><td align="center" rowspan="1" colspan="1">0.010</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">61.8&#x000b1;9.1</td><td align="center" rowspan="1" colspan="1">59.7&#x000b1;9</td><td align="center" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">30.5&#x000b1;5.7</td><td align="center" rowspan="1" colspan="1">29.2&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">51.7 (209)</td><td align="center" rowspan="1" colspan="1">41.8 (138)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous MI</td><td align="center" rowspan="1" colspan="1">7.4 (17)</td><td align="center" rowspan="1" colspan="1">7.6 (31)</td><td align="center" rowspan="1" colspan="1">0.495</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous cardiac surgery</td><td align="center" rowspan="1" colspan="1">1.3 (3)</td><td align="center" rowspan="1" colspan="1">2.5 (10)</td><td align="center" rowspan="1" colspan="1">0.379</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting blood glucose (mg/dl)</td><td align="center" rowspan="1" colspan="1">182&#x000b1;59</td><td align="center" rowspan="1" colspan="1">171&#x000b1;54</td><td align="center" rowspan="1" colspan="1">0.023</td></tr><tr><td align="left" rowspan="1" colspan="1">Proteinuria (mg)</td><td align="center" rowspan="1" colspan="1">15.2 (35)</td><td align="center" rowspan="1" colspan="1">12.5 (38)</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="center" rowspan="1" colspan="1">1.2&#x000b1;0.89</td><td align="center" rowspan="1" colspan="1">0.95&#x000b1;0.33</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemoglobin (g/dL)</td><td align="center" rowspan="1" colspan="1">12.2&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">13.0&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">RDW (%)</td><td align="center" rowspan="1" colspan="1">15.1&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">14.5&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin (g/dL)</td><td align="center" rowspan="1" colspan="1">3.96&#x000b1;0.47</td><td align="center" rowspan="1" colspan="1">4.1&#x000b1;0.48</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Uric acid (mg/dL)</td><td align="center" rowspan="1" colspan="1">5.9&#x000b1;2</td><td align="center" rowspan="1" colspan="1">5.3&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">C-reactive protein (mg/L)</td><td align="center" rowspan="1" colspan="1">1.54&#x000b1;2</td><td align="center" rowspan="1" colspan="1">1.61&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">0.742</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF (%)</td><td align="center" rowspan="1" colspan="1">52.6&#x000b1;12.3</td><td align="center" rowspan="1" colspan="1">53.9&#x000b1;11.6</td><td align="center" rowspan="1" colspan="1">0.267</td></tr><tr><td align="left" rowspan="4" colspan="1">Intra-operative data</td><td align="left" rowspan="1" colspan="1">Drainage (mL)</td><td align="center" rowspan="1" colspan="1">550 (350-800)</td><td align="center" rowspan="1" colspan="1">600 (450-800)</td><td align="center" rowspan="1" colspan="1">0.317</td></tr><tr><td align="left" rowspan="1" colspan="1">Intubation time (hour)</td><td align="center" rowspan="1" colspan="1">13 (10-19)</td><td align="center" rowspan="1" colspan="1">10 (8-13)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">ACC time (minutes)</td><td align="center" rowspan="1" colspan="1">54 (32-82)</td><td align="center" rowspan="1" colspan="1">48.5 (33-70)</td><td align="center" rowspan="1" colspan="1">0.024</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="center" rowspan="1" colspan="1">89.5</td><td align="center" rowspan="1" colspan="1">87.3</td><td align="center" rowspan="1" colspan="1">0.412</td></tr><tr><td align="left" rowspan="4" colspan="1">Post-operative data</td><td align="left" rowspan="1" colspan="1">ICU stay (days)</td><td align="center" rowspan="1" colspan="1">70 (39-121)</td><td align="center" rowspan="1" colspan="1">55 (24-71)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine, first day (mg/dL)</td><td align="center" rowspan="1" colspan="1">1.6&#x000b1;1</td><td align="center" rowspan="1" colspan="1">0.95&#x000b1;0.31</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine, second day (mg/dL)</td><td align="center" rowspan="1" colspan="1">1.67&#x000b1;1</td><td align="center" rowspan="1" colspan="1">0.88&#x000b1;0.30</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine, third day (mg/dL)</td><td align="center" rowspan="1" colspan="1">1.71&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">0.90&#x000b1;0.34</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>ACC=aortic cross-clamping; AKI=acute kidney injury; BMI=body mass index;
CPB=cardiopulmonary bypass; ICU=intensive care unit; LVEF=left
ventricular ejection fraction; MI=myocardial infarction; RDW=red cell
distribution width</p></fn></table-wrap-foot></table-wrap><p>Female gender, older age, high body mass index (BMI) level, existence of HT,
preoperative proteinuria, high baseline creatinine level, low Hgb, low albumin
level, high uric acid level, and long ACC time were found to be related with high
AKI development risk in univariate analysis. Multiple logistic regression analysis
was used to determine the independent predictors of postoperative AKI development.
High BMI levels (odds ratio [OR] and 95% confidence interval [CI], 1.066
[1.002-1.135]; <italic>P</italic>=0.043), existence of HT (OR and 95% CI, 2.153
[1.023-4.531]; <italic>P</italic>=0.043), existence of preoperative proteinuria (OR
and 95% CI, 2.454 [1.007-5.984]; <italic>P</italic>=0.048), and low preoperative
albumin levels (OR and 95% CI, 0.453 [0.216-0.947]; <italic>P</italic>=0.035) were
found to be independent predictors for postoperative AKI development (<xref rid="t2" ref-type="table">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Multivariate predictors for acute kidney injury after coronary artery bypass
grafting.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Univariate OR, 95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th><th align="center" rowspan="1" colspan="1">Multivariate OR, 95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Male (N)</td><td align="center" rowspan="1" colspan="1">0.644(0.460-0.902)</td><td align="center" rowspan="1" colspan="1">0.010</td><td align="center" rowspan="1" colspan="1">0.572(0.288-1.137)</td><td align="center" rowspan="1" colspan="1">0.111</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">1.026(1.008-1.045)</td><td align="center" rowspan="1" colspan="1">0.005</td><td align="center" rowspan="1" colspan="1">1.006(0.971-1.043)</td><td align="center" rowspan="1" colspan="1">0.725</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI</bold></td><td align="center" rowspan="1" colspan="1"><bold>1.046(1.012-1.082)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.007</bold></td><td align="center" rowspan="1" colspan="1"><bold>1.066(1.002-1.135)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.043</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hypertension</bold></td><td align="center" rowspan="1" colspan="1"><bold>2.195(1.434-3.360)</bold></td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1"><bold>2.153(1.023-4.531)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.043</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Proteinuria (mg)</bold></td><td align="center" rowspan="1" colspan="1"><bold>2.094(1.260-3.480)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.004</bold></td><td align="center" rowspan="1" colspan="1"><bold>2.454(1.007-5.984)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.048</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative Hgb (g/dL)</td><td align="center" rowspan="1" colspan="1">0.760(0.687-0.841)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">1.111(0.882-1.400)</td><td align="center" rowspan="1" colspan="1">0.370</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative RDW (%)</td><td align="center" rowspan="1" colspan="1">1.218(1.106-1.342)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">1.045(0.862-1.266)</td><td align="center" rowspan="1" colspan="1">0.657</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline creatinine (mg/dL)</td><td align="center" rowspan="1" colspan="1">2.260(1.560-3.273)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">1.150(0.609-2.172)</td><td align="center" rowspan="1" colspan="1">0.665</td></tr><tr><td align="left" rowspan="1" colspan="1">Preop uric acid(mg/dL)</td><td align="center" rowspan="1" colspan="1">1.189(1.065-1.328)</td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">1.086(0.918-1.284)</td><td align="center" rowspan="1" colspan="1">0.336</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Preoperative albumin (g/dL)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.426(0.292-0.620)</bold></td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.453(0.216-0.947)</bold></td><td align="center" rowspan="1" colspan="1"><bold>0.035</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">ACC time (minutes)</td><td align="center" rowspan="1" colspan="1">1.006(1.001-1.012)</td><td align="center" rowspan="1" colspan="1">0.024</td><td align="center" rowspan="1" colspan="1">1.001(0.993-1.009)</td><td align="center" rowspan="1" colspan="1">0.847</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>ACC=aortic cross-clamping; BMI=body mass index; CI=confidence interval;
Hgb=hemoglobin; OR=odds ratio; RDW=red cell distribution width</p></fn></table-wrap-foot></table-wrap><p>AKI developed patients had statistically significant lower serum albumin levels but
higher rates of HT existence, proteinuria, and higher BMI levels than non-AKI
patients (<xref rid="t1" ref-type="table">Table 1</xref>, <xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Preoperative serum albumin according to the acute kidney injury (AKI)
stage. CI=confidence interval; KDIGO=Kidney Disease: Improving Global
Outcomes</p></caption><graphic xlink:href="rbccv-34-05-0565-g01"/></fig>
</p><p>The diagnostic performance analysis made for each independent predictor showed that
HT existence results in AKI development with a sensitivity of 78.8% and a
specificity of 37% as proteinuria leads to AKI development with a sensitivity of 23%
and a specificity of 88.3%. ROC curve analyses showed that albumin levels &#x0003c;3
mg/dL have 83% sensitivity and 10% specificity for predicting AKI development while
BMI &#x0003e;29 has a 57% sensitivity and 53% specificity (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Receiver operating characteristic (ROC) curve plot for preoperative serum
albumin in prediction of acute kidney injury (AKI). AUC=area under the
curve</p></caption><graphic xlink:href="rbccv-34-05-0565-g02"/></fig>
</p><p>A one way-repeated measures ANOVA was conducted to determine the SCr level over the
first three postoperative days in AKI and non-AKI groups. The assumption of
sphericity was violated (Mauchly's test <italic>P</italic> value &#x0003c;0.001). There
was a statistically significant change in creatinine level over three days in both
groups. A significant increase in creatinine levels on postoperative first, second,
and third days was observed in the AKI group (<xref ref-type="fig" rid="f3">Figure
3</xref>).</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Estimated marginal means of creatinine. AKI=acute kidney injury</p></caption><graphic xlink:href="rbccv-34-05-0565-g03"/></fig>
</p><p>In the overall population, the incidence of all-cause mortality was 8.2% (n=52) and
of postoperative infection was 11% (n=70). Non-AKI patients were associated with
less all-cause mortality (17.4% <italic>vs</italic>. 3.0%,
<italic>P</italic>&#x0003c;0.001) and postoperative infection (16.5% <italic>vs</italic>.
7.9%, <italic>P</italic>=0.001).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>AKI following CPB is an important cause of morbidity and mortality<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. In this study, our aim was to
research the effect of preoperative low serum albumin levels on postoperative AKI
development in diabetic patients undergoing isolated CABG operation.</p><p>AKI development subsequent to cardiac surgery is related with increased morbidity,
mortality, and prolonged in-hospital stay. The incidence of AKI is 5%-30% after
cardiac surgical procedures. Renal replacement therapy due to AKI development is the
independent risk factor of mortality<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>. AKI following
cardiac surgery is multi-factorial. The known risk factors are old age, diabetes,
low preoperative glomerular filtration rate (GFR) (&#x0003c;60 mL/min/m<sup>2</sup>), low
EF (&#x0003c;35%), and administration of nephrotoxic agents. The incidence of AKI was
found to be high in patients with DM<sup>[<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Our results
showed that preoperative low serum albumin level, high BMI, and preoperative severe
HT are related with enhanced risk of AKI development defined by KDIGO<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> criteria.</p><p>Albumin is the primary protein to maintain the plasma oncotic pressure as it obtains
70% of the oncotic pressure<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>.
It's an anti-inflammatory, antioxidant, and anticoagulant protein. Hypoalbuminemia
is an indicator for liver and renal insufficiency. And hypoalbuminemia was found to
be associated with increased mortality and morbidity subsequent to various surgical
procedures in many studies<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Many
studies have shown albumin not only to be an inflammatory marker but also an AKI
predictor. Also, hypoalbuminemia is a strong predictor for end-stage renal failure.
Albumin protects renal function by increasing the oncotic pressure in coronary
artery disease patients, it provides the continuation of renal perfusion and
improves the glomerular filtration, and it protects the kidneys from toxic agents.
The effect of hypoalbuminemia on postoperative renal failure was shown in many
studies<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Foley
et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> showed that there is a
strong correlation between hypoalbuminemia and ischemic heart disease. The same
study revealed the need for hemodialysis in patients with low albumin levels in the
same group of patients<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>.
Wiedermann et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup> showed
hypoalbuminemia as an independent risk factor for AKI.</p><p>In the presented studies, it is shown that low serum albumin levels enhance the
incidence of AKI development in patients who underwent CABG surgical procedure. Lee
et al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup> performed a
single-center, randomized, double blind trial with patients whose preoperative
albumin level was &#x0003c;4mg/dL. They found out that a decreasing in serum albumin
levels was associated with AKI. F&#x00131;nd&#x00131;k et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> have searched the relation
between AKI and CABG procedure and have shown that patients with albumin levels
&#x0003c;3.5 g/dL are tend to develop AKI more often. Patients with diabetes who
underwent CABG procedure in our centre were isolatelly-maintained and had their
details observed in this study. Serum albumin levels &#x0003c;3 g/dL are the independent
risk factor for AKI development in diabetic patients who underwent CABG surgical
procedure.</p><p>Engelman et al. found low BMI and low serum albumin levels associated with high
postoperative mortality and morbidity in a study with 5168 CABG patients. The same
study revealed that a low serum albumin level (&#x0003c;2.5g/dL) is an independent risk
factor for postoperative bleeding, prolonged ICU stay, prolonged mechanical
ventilation, and renal failure. This study also showed that a high BMI is related
with increased sternum and saphenous vein wound infection risk<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. However, our study found out that
a high BMI is an independent risk factor of postoperative AKI development.</p><p>Wu et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> found preoperative
proteinuria related with AKI development and as an independent risk factor for
end-stage renal failure after CABG surgery. Hsu et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup> evaluated the data of 600.000 patients and
revealed that proteinuria and decrease in GFR are the independent risk factors for
AKI development. Similarly, our study also found proteinuria as an independent risk
factor for postoperative AKI development. In our study, high BMI, history of HT, and
proteinuria were not found associated with AKI stage, except for the relation
between presence of proteinuria and stage-3 AKI.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>We showed that preoperative low serum albumin level, high BMI, preoperative HT, and
proteinuria are associated with AKI development, defined by the KDIGO
classification, in the diabetic patients who underwent CABG surgical procedure
postoperatively.</p><p>Serum albumin level &#x0003c;3 g/dL is an independent risk factor for AKI development in
the isolated diabetic patients who underwent CABG surgical procedure. We emphasize
that this adjustable albumin level should be considered before the operation since
it is an easy and clinically implementable management for the prevention of AKI
development.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="border-bottom-width:thin;border-bottom-style:solid" rowspan="1">Authors'
roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RA</td><td align="center" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">TA</td><td align="center" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">EY</td><td align="center" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">DC</td><td align="center" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">MS</td><td align="center" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">CK</td><td align="center" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">MBR</td><td align="center" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Kartal Kosuyolu Training and Research Hospital,
Department of Cardiovascular Surgery, Istanbul, Turkey.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>Z</given-names></name><name><surname>Hakanson</surname><given-names>E</given-names></name><name><surname>Svedjeholm</surname><given-names>R</given-names></name></person-group><article-title>Early postoperative outcome and medium-term survival in 540
diabetic and 2239 nondiabetic patients undergoing coronary artery bypass
grafting</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>74</volume><issue>3</issue><fpage>712</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/S0003-4975(02)03778-5</pub-id><pub-id pub-id-type="pmid">12238829</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>Y</given-names></name><name><surname>Raz</surname><given-names>I</given-names></name><name><surname>Merin</surname><given-names>G</given-names></name><name><surname>Mozes</surname><given-names>B</given-names></name></person-group><article-title>Comparison of factors associated with 30-day mortality after
coronary artery bypass grafting in patients with versus without diabetes
mellitus. Israeli Coronary Artery Bypass (ISCAB) Study
Consortium</article-title><source>Am J Cardiol</source><year>1998</year><volume>81</volume><issue>1</issue><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0002-9149(97)00797-2</pub-id><pub-id pub-id-type="pmid">9462597</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubal</surname><given-names>C</given-names></name><name><surname>Srinivasan</surname><given-names>AK</given-names></name><name><surname>Grayson</surname><given-names>AD</given-names></name><name><surname>Fabri</surname><given-names>BM</given-names></name><name><surname>Chalmers</surname><given-names>JA</given-names></name></person-group><article-title>Effect of risk-adjusted diabetes on mortality and morbidity after
coronary artery bypass surgery</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>79</volume><issue>5</issue><fpage>1570</fpage><lpage>1576</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2004.10.035</pub-id><pub-id pub-id-type="pmid">15854935</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>S</given-names></name><name><surname>Shehabi</surname><given-names>Y</given-names></name><name><surname>Pickering</surname><given-names>JW</given-names></name><name><surname>Endre</surname><given-names>Z</given-names></name><name><surname>Miyashita</surname><given-names>T</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name></person-group><article-title>Perioperative change in creatinine following cardiac surgery with
cardiopulmonary bypass is useful in predicting acute kidney injury: a
single-centre retrospective cohort study</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2015</year><volume>21</volume><issue>4</issue><fpage>465</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1093/icvts/ivv184</pub-id><pub-id pub-id-type="pmid">26160965</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousefshahi</surname><given-names>F</given-names></name><name><surname>Yasseri</surname><given-names>AMF</given-names></name><name><surname>Barkhordari</surname><given-names>K</given-names></name><name><surname>Amini</surname><given-names>M</given-names></name><name><surname>Omran</surname><given-names>AS</given-names></name><name><surname>Hemami</surname><given-names>MR</given-names></name><name><surname>Asadi</surname><given-names>M</given-names></name></person-group><article-title>Incidence and complications of acute kidney injury following
coronary artery bypass graft: a retrospective cohort study</article-title><source>Iran J Kidney Dis</source><comment>[Internet]</comment><year>2015</year><date-in-citation content-type="access-date">2019 Apr 27</date-in-citation><volume>9</volume><issue>2</issue><fpage>113</fpage><lpage>118</lpage><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://pdfs.semanticscholar.org/f2bb/98928e330dd1ae6245ca45f2edcb00cacfad.pdf">https://pdfs.semanticscholar.org/f2bb/98928e330dd1ae6245ca45f2edcb00cacfad.pdf</ext-link></comment><pub-id pub-id-type="pmid">25851289</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>MY</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Baek</surname><given-names>SH</given-names></name><name><surname>Na</surname><given-names>KY</given-names></name><name><surname>Chae</surname><given-names>DW</given-names></name><name><surname>Chin</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Hypoalbuminemia at admission predicts the development of acute
kidney injury in hospitalized patients: a retrospective cohort
study</article-title><source>PLoS One</source><day>19</day><month>7</month><year>2017</year><volume>12</volume><issue>7</issue><elocation-id>e0180750</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0180750</pub-id><pub-id pub-id-type="pmid">28723973</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelman</surname><given-names>DT</given-names></name><name><surname>Adams</surname><given-names>DH</given-names></name><name><surname>Byrne</surname><given-names>JG</given-names></name><name><surname>Aranki</surname><given-names>SF</given-names></name><name><surname>Collins Jr</surname><given-names>JJ</given-names></name><name><surname>Couper</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Impact of body mass index and albumin on morbidity and mortality
after cardiac surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>1999</year><volume>118</volume><issue>5</issue><fpage>866</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1016/S0022-5223(99)70056-5</pub-id><pub-id pub-id-type="pmid">10534692</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado-Rodr&#x000ed;guez</surname><given-names>M</given-names></name><name><surname>Medina-Cuadros</surname><given-names>M</given-names></name><name><surname>G&#x000f3;mez-Ortega</surname><given-names>A</given-names></name><name><surname>Mart&#x000ed;nez-Gallego</surname><given-names>G</given-names></name><name><surname>Mariscal-Ortiz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cholesterol and serum albumin levels as predictors of cross
infection, death, and length of hospital stay</article-title><source>Arch Surg</source><year>2002</year><volume>137</volume><issue>7</issue><fpage>805</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1001/archsurg.137.7.805</pub-id><pub-id pub-id-type="pmid">12093337</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Lameire</surname><given-names>N</given-names></name><name><surname>Aspelin</surname><given-names>P</given-names></name><name><surname>Barsoum</surname><given-names>RS</given-names></name><name><surname>Burdmann</surname><given-names>EA</given-names></name><name><surname>Goldstein</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Kidney disease: improving global outcomes (KDIGO) acute kidney
injury work group. KDIGO clinical practice guideline for acute kidney
injury</article-title><source>Kidney International Supplements</source><year>2012</year><volume>2</volume><issue>1</issue><fpage>1</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1038/kisup.2012.1</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genuth</surname><given-names>S</given-names></name><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Bennett</surname><given-names>P</given-names></name><name><surname>Buse</surname><given-names>J</given-names></name><name><surname>Defronzo</surname><given-names>R</given-names></name><name><surname>Kahn</surname><given-names>R</given-names></name><etal/></person-group><article-title>Expert Committee on the Diagnosis and Classification of Diabetes
Mellitus</article-title><source>Diabetes Care</source><year>2003</year><volume>26</volume><issue>11</issue><fpage>3160</fpage><lpage>3160</lpage><pub-id pub-id-type="pmid">14578255</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furnary</surname><given-names>AP</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Bookin</surname><given-names>SO</given-names></name></person-group><article-title>Effect of hyperglycemia and continuous intravenous insulin
infusions on outcomes of cardiac surgical procedures: the Portland diabetic
project</article-title><source>Endocr Pract</source><year>2004</year><volume>10</volume><issue>Suppl 2</issue><fpage>21</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.4158/EP.10.S2.21</pub-id><pub-id pub-id-type="pmid">15251637</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeland</surname><given-names>K</given-names></name><name><surname>Hamidian Jahromi</surname><given-names>A</given-names></name><name><surname>Duvall</surname><given-names>LM</given-names></name><name><surname>Mancini</surname><given-names>MC</given-names></name></person-group><article-title>Postoperative blood transfusion is an independent predictor of
acute kidney injury in cardiac surgery patients</article-title><source>J Nephropathol</source><year>2015</year><volume>4</volume><issue>4</issue><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.12860/jnp.2015.23</pub-id><pub-id pub-id-type="pmid">26457259</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>KI</given-names></name><name><surname>Bakaeen</surname><given-names>FG</given-names></name><name><surname>Wang</surname><given-names>XL</given-names></name><name><surname>Huh</surname><given-names>J</given-names></name><name><surname>LeMaire</surname><given-names>S</given-names></name><name><surname>Coselli</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Hypoalbuminemia and long-term survival after coronary artery
bypass: a propensity score analysis</article-title><source>Ann Thorac Surg</source><year>2011</year><volume>91</volume><issue>3</issue><fpage>671</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2010.09.004</pub-id><pub-id pub-id-type="pmid">21352977</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bove</surname><given-names>T</given-names></name><name><surname>Calabro</surname><given-names>MG</given-names></name><name><surname>Landoni</surname><given-names>G</given-names></name><name><surname>Aletti</surname><given-names>G</given-names></name><name><surname>Marino</surname><given-names>G</given-names></name><name><surname>Crescenzi</surname><given-names>G</given-names></name><etal/></person-group><article-title>The incidence and risk of acute renal failure after cardiac
surgery</article-title><source>J Cardiothorac Vasc Anesth</source><year>2004</year><volume>18</volume><issue>4</issue><fpage>442</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2004.05.021</pub-id><pub-id pub-id-type="pmid">15365924</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maitra</surname><given-names>G</given-names></name><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>Rudra</surname><given-names>A</given-names></name><name><surname>Wankhede</surname><given-names>R</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>T</given-names></name></person-group><article-title>Renal dysfunction after off-pump coronary artery bypass
surgery-risk factors and preventive strategies</article-title><source>Indian J Anaesth</source><comment>[Internet]</comment><year>2009</year><date-in-citation content-type="access-date">2019 Apr 27</date-in-citation><volume>53</volume><issue>4</issue><fpage>401</fpage><lpage>407</lpage><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894497/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894497/</ext-link></comment><pub-id pub-id-type="pmid">20640201</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karkouti</surname><given-names>K</given-names></name><name><surname>Beattie</surname><given-names>WS</given-names></name><name><surname>Wijeysundera</surname><given-names>DN</given-names></name><etal/></person-group><article-title>Hemodilution during cardiopulmonary bypass is an independent risk
factor for acute renal failure in adult cardiac surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2005</year><volume>129</volume><issue>2</issue><fpage>391</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2004.06.028</pub-id><pub-id pub-id-type="pmid">15678051</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanali</surname><given-names>G</given-names></name><name><surname>di Masi</surname><given-names>A</given-names></name><name><surname>Trezza</surname><given-names>V</given-names></name><name><surname>Marino</surname><given-names>M</given-names></name><name><surname>Fasano</surname><given-names>M</given-names></name><name><surname>Ascenzi</surname><given-names>P</given-names></name></person-group><article-title>Human serum albumin: from bench to bedside</article-title><source>Mol Aspects Med</source><year>2012</year><volume>33</volume><issue>3</issue><fpage>209</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2011.12.002</pub-id><pub-id pub-id-type="pmid">22230555</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>A</given-names></name><name><surname>Ramirez</surname><given-names>M</given-names></name><name><surname>Cueva</surname><given-names>L</given-names></name><name><surname>Alvarez</surname><given-names>S</given-names></name><name><surname>de Loza</surname><given-names>R</given-names></name><name><surname>Gamba</surname><given-names>G</given-names></name></person-group><article-title>Low serum albumin and the increased risk of amikacin
nephrotoxicity</article-title><source>Rev Invest Clin</source><comment>[Internet]</comment><year>1993</year><date-in-citation content-type="access-date">2019 Apr 27</date-in-citation><volume>46</volume><issue>1</issue><fpage>37</fpage><lpage>43</lpage><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/8079062">https://www.ncbi.nlm.nih.gov/pubmed/8079062</ext-link></comment></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamlauski-Tucker</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>JJ</given-names></name></person-group><article-title>Effect of substrate-free albumin on perfused rat kidney
function</article-title><source>Ren Physiol</source><year>1988</year><volume>10</volume><issue>6</issue><fpage>352</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1159/000173144</pub-id><pub-id pub-id-type="pmid">3231893</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foley</surname><given-names>RN</given-names></name><name><surname>Parfrey</surname><given-names>PS</given-names></name><name><surname>Harnett</surname><given-names>JD</given-names></name><name><surname>Kent</surname><given-names>GM</given-names></name><name><surname>Murray</surname><given-names>DC</given-names></name><name><surname>Barre</surname><given-names>PE</given-names></name></person-group><article-title>Hypoalbunemia, cardiac morbidity and mortality in end-stage renal
disease</article-title><source>J Am Soc Nephrol</source><comment>[Internet]</comment><year>1996</year><date-in-citation content-type="access-date">2019 Apr 27</date-in-citation><volume>7</volume><issue>5</issue><fpage>728</fpage><lpage>736</lpage><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://jasn.asnjournals.org/content/7/5/728">https://jasn.asnjournals.org/content/7/5/728</ext-link></comment><pub-id pub-id-type="pmid">8738808</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wedermann</surname><given-names>CI</given-names></name><name><surname>Wedermann</surname><given-names>W</given-names></name><name><surname>Joannidis</surname><given-names>M</given-names></name></person-group><year>2010</year><article-title>Hypoalbuminemia and acute kidney injury: a meta-analysis of
observational clinical studies</article-title><source>Intensive Care Med</source><volume>36</volume><issue>10</issue><fpage>1657</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.1007/s00134-010-1928-z</pub-id><pub-id pub-id-type="pmid">20517593</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>EH</given-names></name><name><surname>Kim</surname><given-names>WJ</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Chin</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>DK</given-names></name><name><surname>Sim</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Effect of exogenous albumin on the incidence of postoperative
acute kidney injury in patients undergoing off-pump coronary artery bypass
surgery with a preoperative albumin level of less than 4.0
g/dl</article-title><source>Anesthesiology</source><year>2016</year><volume>124</volume><issue>5</issue><fpage>1001</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1097/ALN.0000000000001051</pub-id><pub-id pub-id-type="pmid">26891150</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Findik</surname><given-names>O</given-names></name><name><surname>Aydin</surname><given-names>U</given-names></name><name><surname>Baris</surname><given-names>O</given-names></name><name><surname>Parlar</surname><given-names>H</given-names></name><name><surname>Alagoz</surname><given-names>GA</given-names></name><name><surname>Ata</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Preoperative low serum albumin levels increase the requirement of
renal replacement therapy after cardiac surgery</article-title><source>Heart Surg Forum</source><year>2016</year><volume>19</volume><issue>3</issue><fpage>E123</fpage><lpage>E127</lpage><pub-id pub-id-type="doi">10.1532/hsf.1577</pub-id><pub-id pub-id-type="pmid">27355147</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>V-C</given-names></name><name><surname>Huang</surname><given-names>T-M</given-names></name><name><surname>Wu</surname><given-names>P-C</given-names></name><name><surname>Wang</surname><given-names>W-J</given-names></name><name><surname>Chao</surname><given-names>C-T</given-names></name><name><surname>Yang</surname><given-names>SY</given-names></name><etal/></person-group><year>2012</year><article-title>Preoperative proteinuria is associated with long-term progression
to chronic dialysis and mortality after coronary artery bypass grafting
surgery</article-title><source>PLoS One</source><volume>7</volume><issue>1</issue><elocation-id>e27687</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0027687</pub-id><pub-id pub-id-type="pmid">22276092</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>RK</given-names></name><name><surname>Hsu</surname><given-names>C</given-names></name></person-group><article-title>Proteinuria and reduced glomerular filtration rate as risk
factors for acute kidney injury</article-title><source>Curr Opin Nephrol Hypertens</source><year>2011</year><volume>20</volume><issue>3</issue><fpage>211</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1097/MNH.0b013e3283454f8d</pub-id><pub-id pub-id-type="pmid">21455065</pub-id></element-citation></ref></ref-list></back></article>